Alhadrami Hani A, Alkhatabi Heba, Abduljabbar Fahad H, Abdelmohsen Usama Ramadan, Sayed Ahmed M
Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Molecular Diagnostic Lab., King Abdulaziz University Hospital, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Pharmaceutics. 2021 Nov 3;13(11):1846. doi: 10.3390/pharmaceutics13111846.
-derived natural products have shown promising anticancer properties against many human cancer cell lines. In the present investigation, we found that an ethyl acetate extract of (CE) collected from the Red Sea could inhibit the human breast cancer (BC) cells (MCF and MDA-MB-231) in vitro (IC 24.32 ± 1.1 and 9.55 ± 0.19 µg/mL, respectively). The subsequent incorporation of the extract into the green synthesis of silver nanoparticles (AgNPs) resulted in significantly more activity against both cancer cell lines (IC 5.62 ± 0.89 and 1.72 ± 0.36, respectively); the efficacy was comparable to that of doxorubicin with much-enhanced selectivity. To explore the mode of action of this extract, various in silico and network-pharmacology-based analyses were performed in the light of the LC-HRESIMS-identified compounds in the CE extract. Firstly, using two independent machine-learning-based prediction software platforms, most of the identified compounds in CE were predicted to inhibit both MCF7 and MDA-MB-231. Moreover, they were predicted to have low toxicity towards normal cell lines. Secondly, approximately 242 BC-related molecular targets were collected from various databases and used to construct a protein-protein interaction (PPI) network, which revealed the most important molecular targets and signaling pathways in the pathogenesis of BC. All the identified compounds in the extract were then subjected to inverse docking against all proteins hosted in the Protein Data bank (PDB) to discover the BC-related proteins that these compounds can target. Approximately, 10.74% of the collected BC-related proteins were potential targets for 70% of the compounds identified in CE. Further validation of the docking results using molecular dynamic simulations (MDS) and binding free energy calculations revealed that only 2.47% of the collected BC-related proteins could be targeted by 30% of the CE-derived compounds. According to docking and MDS experiments, protein-pathway and compound-protein interaction networks were constructed to determine the signaling pathways that the CE compounds could influence. This paper highlights the potential of marine natural products as effective anticancer agents and reports the discovery of novel anti-breast cancer AgNPs.
源自[具体名称未给出]的天然产物已显示出对多种人类癌细胞系具有有前景的抗癌特性。在本研究中,我们发现从红海采集的[具体名称未给出]的乙酸乙酯提取物(CE)在体外可抑制人乳腺癌(BC)细胞(MCF和MDA - MB - 231)(IC分别为24.32±1.1和9.55±0.19 µg/mL)。随后将该提取物用于绿色合成银纳米颗粒(AgNPs),结果显示对两种癌细胞系的活性显著增强(IC分别为5.62±0.89和1.72±0.36);其疗效与阿霉素相当,且选择性大大提高。为探究该提取物的作用模式,根据LC - HRESIMS鉴定的CE提取物中的化合物,进行了各种基于计算机模拟和网络药理学的分析。首先,使用两个独立的基于机器学习的预测软件平台,预测CE中大多数已鉴定的化合物可抑制MCF7和MDA - MB - 231。此外,预测它们对正常细胞系具有低毒性。其次,从各种数据库收集了约242个与BC相关的分子靶点,并用于构建蛋白质 - 蛋白质相互作用(PPI)网络,该网络揭示了BC发病机制中最重要的分子靶点和信号通路。然后将提取物中所有已鉴定的化合物与蛋白质数据库(PDB)中包含的所有蛋白质进行反向对接,以发现这些化合物可靶向的与BC相关的蛋白质。大约,收集到的与BC相关的蛋白质中有10.74%是CE中70%已鉴定化合物的潜在靶点。使用分子动力学模拟(MDS)和结合自由能计算对对接结果进行进一步验证,结果显示收集到的与BC相关的蛋白质中只有2.47%可被30%的CE衍生化合物靶向。根据对接和MDS实验,构建了蛋白质 - 途径和化合物 - 蛋白质相互作用网络,以确定CE化合物可能影响的信号通路。本文强调了海洋天然产物作为有效抗癌剂的潜力,并报道了新型抗乳腺癌AgNPs的发现。